14 partners. 37 people involved. 10 countries. 1 mission
EXODUS S.A. (brand name EXUS) is a software house with offices in Athens and London, with strong background in delivering complex systems and solutions in various countries over the world. Our purpose is to improve the business of those we serve, simplifying complexity to enable intelligent action. EXODUS’ main expertise exists with developing cutting edge products for the Banking Sector and Internet and Mobile Technologies.
Both products and bespoke solutions built by EXUS, serve demanding and critical business applications and domains, covering all types of diverse sectors. From consumer banking applications, smartphones-based payment and transaction systems, augmented-reality mobile applications, large-scale and complex portals, extranets, Electronic Data Interchanges to secure cloud services, EXUS covers a wide spread of activities by leveraging the expertise of its 130 people strong technology units that are led by expert project managers and senior consultants.
We have a strong portfolio of major customers in sectors such as Banking, Telecoms, Utilities, Business Consultancies, Media, Real Estate and Hospitality. Our solutions cover a very wide range of demanding Web and Mobile applications, including transaction heavy intranets and extranets, e-learn and e-payment, as well as customized applications pertaining to enterprise needs. In the past four years, we have expanded our scope to incorporate Mobile Applications in smart phones and tablets, covering the iOS, Android and Windows Mobile platforms.
Furthermore, the company operates its internal Innovation department which is responsible for a large number of research activities. Our Innovation Attractor manages a portfolio of initiatives that aim to pave the way for the introduction and take up of emerging technologies. Leveraging the results of strategic research activities allows us to harness untapped niches in our market sectors of interest. We excel in driving innovation in software engineering and data management to foster advances in key sectors such as: security, health, creativity and lifelong learning.
EXUS has been awarded with the EFQM “Recognized for Excellence” award and over the years EXUS has been included among the 20 best places to work in Greece (within the “Great Places to Work®” annual competition). EXUS is certified with ISO:9001 for quality assurance. Our project managers are certified according to the Project Management Institute as Project Management Professionals. Finally, EXUS is a Gold Microsoft and Oracle Partner for development and Integration works.
EXUS has extensive experience in software design and development and provides solutions and services in the areas of web based complex application, eHealth, eLearning, Business Process Management, Professional Services, BI, Debt Collection and Recovery, Financial services, mobile applications. EXUS develops applications following the latest trends in software development: using web services, SOAs, J2EE and adopts the relevant standards”
ICCS has a long track record in developing design- and run-time techniques for the optimization of embedded systems based on digital systems design of multicore/many-core and reconfigurable systems. More specifically, ICCS group has more than 12 years of experience on development middleware services, design space exploration for static and dynamic memory management, data access scheduling, data type refinement in terms of performance, power consumption, memory footprint and reliability design criteria. In the area of embedded systems design
Assoc. Professor in School of ECE of National Technical University of Athens
PhD, Senior Research Assoc. of the Microprocessors and Digital Systems Laboratory at NTUA
Research Assoc. in Microprocessors and Digital Systems Laboratory of the Institute of Communication and Computer Systems (ICCS) of National Technical University of Athens
Kingston University London is an innovative modern research led University which has four campuses and five faculties catering for over 23,000 students. The largest of these Faculties in terms of staff and student numbers is the Faculty of Science, Engineering and Computing (SEC) which isa recent amalgamation of three former Faculties. The SEC Faculty has eight schools:
Pharmacy and Chemistry, Computing Information Sciences, Mathematics, Life Science, Geology, Geography and Environment, Civil Engineering, Mechanical and Automotive Engineering and Aerospace and Aircraft Engineering. SEC is strategically focussed on inter-disciplinary research and researchers in SEC collaborate widely, within the Faculty, across Faculties as well as with a wide range of national and international partners, academic and industrial.
Kingston University has affiliation with a large teaching hospital (St George’s Hospital) and excellent strategic partnerships with healthcare providers across London and the UK which has enabled collaborative links with large databases. This complements the development within Kingston University of strategic links between the Medical Information and Network Technologies (MINT) Research Centre and the Interdisciplinary Hub for the Study of Health and Age related Conditions (IhSHA). MINT has received a number of prestigious grants totalling over £2 million and IhSHA receives support from the EU, leading charities and research councils, which has exceeded £1million in the last two years. The interdisciplinary partnerships across the Research Centres have resulted in successful research teams with complementary skills in areas of mobile healthcare and telemedicine.
The University invests heavily in research infrastructure in the sciences and computing and has recently completed construction of a major laboratory for interdisciplinary research between the biological, pharmaceutical and computer sciences. The facility has state of the art instrumentation for proteomic and genomic analyses, a tissue culture laboratory and computing suite which houses high spec computers for complex analytical work. A range of other laboratories that support life sciences and pharmaceutical research accommodate extensive modern suites for pathogen research, molecular microbiology/GM, natural products analysis, cell signalling, histology, immunology, and microscopy/image analysis. Major new equipment includes 400 and 600 MHz NMR Bruker spectrometers, mass spectroscopy (ICP-MS, ICP-AES, 3x LC-MS/MS, 2 x GC-MS) laser infrared microscope, laser Raman spectrophotometer, X-ray diffractometer, high-resolution microscopes (SEM, TEM, CLSM), flow cytometers/FACS, BodPod, and Ion-Torrent sequencer for genomic analysis..
Country. United Kingdom
The Centre for Research and Technology Hellas (CERTH) was founded in 2000 and is the largest research centre in Northern Greece with the mission to carry out basic and applied research with special emphasis on exploiting research results and developing new products and services with industrial, economic and social impact. In 2012, CERTH ranked first among all research centres in Greece regarding theabsorbed funding from the FP7-ICT Programme during the period 2007-2011. The Institute of Applied Biosciences (INAB) at CERTH, which resulted from the merger of the Institutes of Agrobiotechnology (INA) and Biomedical and Biomolecular Research (IBBR), and specifically the Division of Biomedical and Biomolecular Research will participate in AEGLE.
INAB has experience in conducting research in the areas of biomedical informatics, molecular medicine, and the development and evaluation of eHealth / telemonitoring applications.
INAB research activities in Biomedicine, funded by competitive programs (from both the EU and the Greek state) and industrial support, mainly aim at (i) the identification and validation of novel biomarkers enabling better classification of human cancers and improved diagnosis and prognosis assessment; and, (ii) the development of innovative preventive and therapeutic strategies based on a fundamental understanding of disease pathogenesis and evolution towards the implementation of personalized medicine approaches.
Research Fellow in Genetics INAB/CERTH
Assistant Professor, AUTH Informatics for Big Biodata, CERTH/INAB
MD, PhD, Director of the Institute of Applied Biosciences, Head of the Laboratory of Molecular Biology at the G. Papanicolaou Hospital
Prof. Nicos Maglaveras
PhD Electrical Engineering, Director of the Lab of Medical Informatics in Aristotle University Thessaloniki
MSc, PhD, Anesthesiologist-Intensivist and Assistant professor of Intensive Care Medicine at Democritus University of Thrace, Alexandroupolis Hospital, Greece
Maxeler provides complete platforms for High Performance Computing using dataflow supercomputing. By enabling applications to offload computation to dedicated Dataflow Engines (DFEs), Maxeler’s dataflow computers deliver 20-30x improvement in performance/W and performance/space with respect to conventional systems for particular applications. Dataflow Engines are optimized for “Big data” applications, with pipelined hardware architectures optimized for applying repetitive computation to massive datasets with full in-memory processing. For example, a rack of Maxeler MPC-X nodes provides over 15TB of memory.
Maxeler provides complete application platforms, which consist of:
Application: Maxeler teams consist of scientists and engineers who work on applications across a wide set of domains, ranging from life sciences to oil exploration. Maxeler provides complete applications as well as application libraries which allow domain experts to easily create new applications which exploit the performance of dataflow systems.
Compilers and management software: MaxelerOS manages resources, scheduling and data movement within a heterogeneous HPC environment. MaxCompiler provides a Java-based programming infrastructure for dataflow programming.
Hardware: Maxeler hardware systems integrate dataflow engines, custom 1U nodes and conventional CPU nodes with networking and local storage. Balancing hardware resources in the data center based on application requirements removes bottlenecks and significantly improves cost of computing.
Operating from its headquarters and main R&D facilities in London, Maxeler has a strong record of research and development of state-of-the-art science and technology. Through its university program, the company also has research relationships with well over 100 universities around the world.
Country. United Kingdom
VP of Dataflow Software Engineering
PhD, CEO of Maxeler Technologies
Head of MaxAcademy at Maxeler Technologies
Uppsala University (UU) is one of the largest universities in Scandinavia with a long-standing international track record in cancer, in particular regarding translational research of hematological malignancies. The Department of Immunology, Genetics and Pathology is the largest department within the Medical Faculty with a focus on cancer and molecular diagnostics.
UU has lately been reinforced by two novel infrastructures, U-CAN (www.u-can.uu.,se), encompassing systematic and longitudinal sampling of tumors including hematological malignancies, and associated clinico-biological data, and Science for Life Laboratory Uppsala (www.scilifelab.uu.se), aiming to explore the molecular basis of complex disorders including cancer by applying new technologies such as next-generation sequencing.
PhD, Associate Professor in Tumor Biology at Uppsala University
PhD, Researcher at the Department of Immunology Genetics and Pathology, Uppsala University
Richard Rosenquist Brandell
MD, PhD, Professor of Molecular Hematology at Uppsala University and head of the Cancer Genetic Section at Uppsala University Hospital
The Vita-Salute San Raffaele University (USR) is the top-rated School of Medicine in Italy and it provides a US recognized MD degree in English as well as international Ph.D. programs in Molecular Medicine. USR has a specific mission for the education and training of physician scientists with the vision of translational research based on the concept that only continuous research can provide a better medicine for the patients.
USR is located in a Biomedical Research Campus that includes: 1) the affiliated Hospital San Raffaele, a top-quality private, non-profit hospital (1300 beds) covering all main medical and surgical specialties; 2) The San Raffaele Scientific Institute, appointed as a Center of Excellence for Research and Medical Care by the Italian Ministry of Health that yearly provides dedicated funding for biomedical research with the aim of transferring basic research findings into new diagnostic and therapeutic tools.
The Campus comprises the Departments of Biology and Technology Research, a 12.000 m2 building (DIBIT-1) recently expanded by an additional 24.000 m2 of brand new facilities (DIBIT-2) and providing laboratory space for ~500 scientists from disciplines as diverse as neuroscience, gene therapy, clinical sciences, genetics and, related to the task of AEGLE, cancer with a tight interaction between basic and clinical research units.
Post-doc researcher at San Raffaele Biomedical Science Park
MD, Senior Physician in the Clinical Unit of Lymphoid Malignancies at the University affiliated Hospital San Raffaele
MD, PhD, Associate Prof. of Internal Medicine at the Università Vita-Salute San Raffaele, Scientific Coordinator of the Clinical Unit of Lymphoid Malignancies and Head of the Research Unit of B Cell Neoplasia
time.lex is a boutique law firm based in Brussels, specialised in information and technology law in the broadest sense, including privacy protection, data and information management, e-business, intellectual property and telecommunications. Its activities cover all legal issues encountered in the creation, management and exploitation of information and technology, in all of its diverse forms. While time.lex itself is still young, having been founded in July 2007 by prof. Jos Dumortier, Geert Somers and Hans Graux, the team behind it already has an established track record in its field of expertise. Collectively, the founders represent well over 35 years of experience in information and technology law, from an academic, business and policy perspective, spanning every aspect of this discipline.
The time.lex team has extensive experience in most aspects of information and technology law, both from a pragmatic perspective as lawyers at the bar of Brussels, and from a scientific perspective as academics at the Interdisciplinary Centre for Law and ICT of the University of Leuven (K.U.Leuven). The time.lex team is specifically known for its European policy studies in a variety of subjects, including data protection, electronic signatures, electronic identity management, e-business and e-government, in which they can rely on an extensive network of IT law experts covering all European countries. From a business perspective, time.lex frequently assists companies in establishing suitable policies and legal frameworks in their data management activities, including with regard to the cross border transfer and processing of personal data, data security and liability management issues. Its clients include private companies and public sector bodies in the IT sector, financial services, e-health, marketing and e-commerce. Specifically in the area of eHealth a time.lex team headed by Jos Dumortier has authored the 2009 European report on “Legally interoperable eHealth in Europe” (see:
http://www.ehealthnews.eu/download/publications/1755-study-on-the-legal-framework-for-interoperable-ehealth-in-europe). The same team is currently charged in the EAHC study “Overview of the national laws on electronic health records in the EU Member States” (http://ec.europa.eu/eahc/health/tenders_H06_2013.html
Erasmus University Rotterdam (EUR) is a research university, driven by a strong focus on current social issues. The university concentrates its expertise on issues of management, organization and policy in the public and private sectors on the one hand, as well as on the field of sickness and health care. Erasmus University Rotterdam has bundled its education and research in four areas of expertise in which the university has a national and international reputation to maintain: Health, Wealth, Governance and Culture. The university counts as its core tasks: to generate knowledge from research, to share knowledge in education and to transfer knowledge to the community. Its driving forces are academic curiosity, critical reflection and social engagement. The university has an enrollment of almost 23,000 students.
The Erasmus School of Health Policy & Management is involved in national and international research in the fields of policy and organizational sciences with a focus on health care, health economics, medical technology assessment, governance, social medical sciences, health law and health insurance. About 800 students are enrolled in its undergraduate and graduate programs. The Institute for Medical Technology Assessment (iMTA) is a research institute at the EUR that is distinguished by independent and excellent research in medical technology assessment, including health economics and health outcomes research. In addition, the iMTA forms part of the rasmus School of Health Policy & Management.
MSc, PhD Candidate at the Erasmus School of Health Policy & Management, Erasmus University
Prof. Jos Aarts
Assistant Professor of Biomedical Informatics
Prof. Ken Redekop
PhD, Associate Professor of Erasmus School of Health Policy & Management, Erasmus University Rotterdam
Professor Carin Uyl-de Groot
PhD, Professor of Health Technology Assessment at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam
Croydon Health Services NHS Trust is a large integrated healthcare system covering a population of over 330,000 residents. It encompasses acute and community setting for delivery of healthcare.
The Trust was a founding member of the South West London Collaborative Research Network as well as a member of the South London Clinical Research Network. We are also part of the Cancer network for London.
There are both University links with Kingston, as well as clinical and academic links to St George’s and King’s teaching hospitals, and also with The Brompton, Great Ormond Street and The Royal Marsden. The Trust has over 500 inpatient beds, a busy maternity Unit of over 4000 deliveries, as well as Neonatal intensive Care and ITU beds. In the last financial year, there were 60 funded research projects with 35 new projects opened. Over 60 research members are active in research, covering a breath of subjects from the new-born to the elderly. Many of the research projects are collaborative work with local as well as with international institutions. (See www.croydonhealthservices.nhs.uk) Due to the integration of services, the Trust runs some of the community programmes that support social issues.
We have a high incidence of type 2 diabetes due to the diverse local population. There exists a large database of over 6000 diabetic cases. We also work collaboratively with neighbouring hospitals. For the purposes of this project, the Diabetology lead, Dr Steve Hyer, for Epsom and St Helier is collaborating in contributing his diabetic database of over 7000 cases to help increase the profile of big data extraction for this project.
Country. United Kingdom
BSc, MB ChB, MRCP, MRCPCH, FRCP, FRCPCH, R&D Director/Consultant Pediatrician
MB, BS, MRCP, Consultant physician at NHS
MA, MD, FRCP, MBA, Consultant at Epsom & St Helier University NHS Trust
Globaz is a business and marketing consulting company based in Portugal and operating throughout Europe and Africa. Established in 2000, Globaz has branches in 3 countries with more than 30 qualified staff members, including senior executives, consultants and researchers. Globaz delivers consultancy and management services and is specialist in implementing innovation strategies in organisations (innovation processes, organisational development, technology and innovation audits), dissemination activities, technology watch, project management (planning, organising, directing, controlling) and project financing.
Globaz, SA main enabler is the ability to combine their expertise with critique and conceptual repertoire, based on an extensive visual culture, social and psychological perspectives. They are a creative driver that aims at a communicational objective. The services offered by Globaz are divided into seven main areas: design (visual identity, graphic supports, editorial design, product design), multimedia (multimedia applications, multimedia management system, video, iPaper); websites (institutional websites, portals , e-commerce sites Mobile), web marketing (email marketing, search engine marketing, social web marketing, search engine optimization, website management); web applications (intranet and extranet, content management system, web hosting, web domains) and two secondary areas: consulting (marketing plans, communication plan, branding and naming, design communication, content); events (trade show management, corporate events, team building). Globaz is geographically established in a region where the industrial tissue its very focused in textiles, shoes and moulding, keeping with these sectors and trustable and sustainable relationship.
The mission of Globaz is to develop and change people, organizations and businesses by making them more efficient, effective, innovative and profitable through the promotion of innovation and technological development.
Staff at Globaz includes Commission evaluators who have been involved in Framework Programme project and proposal activities since FP6. The company focuses on Innovation and Research Management which includes training and consultancy on innovation and project management aspects of the Framework Programme.
Coordinator of International Coorperation Department
The University Hospital of Heraklion (Pa.G.N.I.) is the largest hospital facility in Crete (800 beds) and one of the largest public hospitals in the country. The Pa.G.N.I. provides secondary and tertiary health care in a wide range of clinical specialties, diagnostic and laboratory tests. It is located 8km away from the city of Heraklion in the area of Stavrakia, next to the School of Medicine of the University of Crete.
Prof. of Intensive Care Medicine of the University of Crete, Director of Intensive Care Unit of The University Hospital of Heraklion
Assistant Professor in Intensive Care Medicine at University of Crete, School of Medicine
Gnúbila France is a consulting firm delivering ICT solutions and professional services axed on Grid and Cloud computing with a special emphasis on e-Health and
Health Information Systems. Gnúbila France justifies of a rich expertise in the establishment and execution of multi-partner collaborations, which it has capitalized upon its involvement in several international initiatives. Gnúbila Technology, on a larger scale, provides cross-sectorial solutions including but not restricted to Information System, Customer Relationship Management and Data Integration for Public Administration, Financial Institutions and Small and Medium Enterprises. Gnúbila is implanted in Argonay in France, in Valencia in Spain and in Bucaramanga, in Colombia.
CEO of Gnúbila France and Director of Biomedical Applications at Gnúbila Technology group, PhD in Computer Sciences
CTO of Gnúbila France, PhD in Computer Sciences
CPO Gnubila (cloud, HealthCare), president BLAM SAS et Annecy Ludique (boardgame)
Nottingham Trent University (NTU) is one of the UK’s largest and most popular universities, with over 28,000 students studying across four campuses. Starting out as the Nottingham Government School of Design in 1843, the university has massively expanded, building a long track record of academic excellence and attracting top academic staff across several disciplines.
Nottingham Trent University won University of the Year at the Times Higher Education Awards 2017, as well as winning Modern University of the Year in The Times and Sunday Times Good University Guide 2018.
Country. United Kingdom